In patients with unprotected left main disease, clinical outcomes of PCI with an everolimus-eluting stent do not appear to be influenced by high anatomical complexity as defined by a SYNTAX score ...

The Syntax score previously has been validated as a predictive tool in patients with stable ischemic CAD and multivessel or left main disease in several trials, notably the randomized SYNTAX trial ...

The SYNTAX score is an anatomical-based tool that has quickly become established for long-term risk prediction after percutaneous coronary intervention (PCI). Since publication of the SYNTAX trial ...

The SYNTAX score, which is recommended by US and European guidelines to help make decisions about the optimal revascularization strategy, was calculated retrospectively by scoring all coronary lesions ...